Camberley, Surrey, 2 August 2010 – Gulmay Medical, a designer and manufacturer of a world-renowned range of superficial and orthovoltage radiotherapy systems that have been essential in supporting healthcare professionals and their patients in over 500 clinics for the past 15 years, has announced that it is becoming Xstrahl Limited, effective immediately. This move will consolidate the company’s broad portfolio, enabling radiation therapy and pioneering research as well as the commercialization of the SARRP research platform. SARRP is the most advanced X-ray system delivering a state-of-the-art Image Guided Micro-Irradiation (IGMI) technique for preclinical and radiation biology research.
Xstrahl’s SARRP research platform is transforming our understanding of radiation therapy, a treatment that is employed in over 50% of cancer patients worldwide, as well as providing the most advanced preclinical platform for validating the efficacy of advanced radiation therapies. In addition, Xstrahl has facilitated in vitro and in vivo radiation based research studies by providing a range of X-ray irradiation cabinets.
Martin Robinson, Managing Director says, “Xstrahl more accurately reflects our new positioning as a provider of complete and specialist clinical solutions that will benefit medical practioners, their patients and researchers. A key driver in enabling us to make these advancements has been the Xstrahl team’s unique, in-depth understanding of X-ray therapy techniques in the clinical environment and expertise in designing and building X-Ray Medical and Research Systems.”
Xstrahl has launched a new website that showcases its clinical and research radiotherapy offerings. Further details can be found at: www.xstrahl.com.
Contacts:
College Hill Tony Stephenson or Gemma Howe + 44 207 866 7860 xstrahl@collegehill.com
Xstrahl Martin Robinson +44 1276 66266
About Xstrahl:
Xstrahl is a leading designer and manufacturer of X-ray systems for use in cancer and dermatology treatments and radiation biology research, providing complete solutions for all X-ray therapy and research applications. Xstrahl has more than 15 years’ experience supporting the X-ray therapy requirements of healthcare providers around the world, from initial specification and suite design through to installation and ongoing training, education and maintenance. In collaboration with researchers, Xstrahl has applied its extensive experience in medical X-ray therapy systems to pioneer the development of the SARRP research platform which enables Image Guided Micro-Irradiation (IGMI™) techniques. The SARRP platform stands to transform the field of radiation biology and preclinical research, enabling advances to be made in the understanding of the use of radiation therapy for the treatment of disease.
Xstrahl has, at its core, an in-depth knowledge and understanding of the clinical environment and radiography techniques, and provides an unrivalled level of training to users of its products. The company is headquartered in the UK with manufacturing facilities both in the UK and USA and operates globally through its international network of distributors.
For additional information about Xstrahl please visit our website: www.xstrahl.com
